Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Science 15 July 1994:
Vol. 265. no. 5170, pp. 334 - 335
DOI: 10.1126/science.8023155
Prev | Table of Contents | Next

Articles

p53: a glimpse at the puppet behind the shadow play

S Friend

No abstract or summary view of this item is available. To view the full-text version, follow this link.

Article topics:

  • Biochemistry..p53
  • Physiology..Humans


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Predictive diagnosis of the cancer prone Li-Fraumeni syndrome by accident: new challenges through whole genome array testing.
T Schwarzbraun, A C Obenauf, A Langmann, U Gruber-Sedlmayr, K Wagner, M R Speicher, and P M Kroisel (2009)
J. Med. Genet. 46, 341-344
   Abstract »    Full Text »    PDF »
Prognostic Significance of p53 Codon 72 Polymorphism Differs with Race in Colorectal Adenocarcinoma.
V. R. Katkoori, X. Jia, C. Shanmugam, W. Wan, S. Meleth, H. Bumpers, W. E. Grizzle, and U. Manne (2009)
Clin. Cancer Res. 15, 2406-2416
   Abstract »    Full Text »    PDF »
Gain of Oncogenic Function of p53 Mutants Induces Invasive Phenotypes in Human Breast Cancer Cells by Silencing CCN5/WISP-2.
G. Dhar, S. Banerjee, K. Dhar, O. Tawfik, M. S. Mayo, P. J. VanVeldhuizen, and S. K. Banerjee (2008)
Cancer Res. 68, 4580-4587
   Abstract »    Full Text »    PDF »
TP53 Mutations and Survival in Squamous-Cell Carcinoma of the Head and Neck.
M. L. Poeta, J. Manola, M. A. Goldwasser, A. Forastiere, N. Benoit, J. A. Califano, J. A. Ridge, J. Goodwin, D. Kenady, J. Saunders, et al. (2007)
N. Engl. J. Med. 357, 2552-2561
   Abstract »    Full Text »    PDF »
Restoration of p53 function for selective Fas-mediated apoptosis in human and rat glioma cells in vitro and in vivo by a p53 COOH-terminal peptide.
P. B. Senatus, Y. Li, C. Mandigo, G. Nichols, G. Moise, Y. Mao, M. D. Brown, R. C. Anderson, A. T. Parsa, P. W. Brandt-Rauf, et al. (2006)
Mol. Cancer Ther. 5, 20-28
   Abstract »    Full Text »    PDF »
Selective induction of apoptosis in mutant p53 premalignant and malignant cancer cells by PRIMA-1 through the c-Jun-NH2-kinase pathway.
Y. Li, Y. Mao, P. W. Brandt-Rauf, A. C. Williams, and R. L. Fine (2005)
Mol. Cancer Ther. 4, 901-909
   Abstract »    Full Text »    PDF »
Identification of Protein Kinase A Catalytic Subunit {beta} as a Novel Binding Partner of p73 and Regulation of p73 Function.
T. Hanamoto, T. Ozaki, K. Furuya, M. Hosoda, S. Hayashi, M. Nakanishi, H. Yamamoto, H. Kikuchi, S. Todo, and A. Nakagawara (2005)
J. Biol. Chem. 280, 16665-16675
   Abstract »    Full Text »    PDF »
Insights into Selective Activation of p53 DNA Binding by c-Abl.
G. Wei, A. G. Li, and X. Liu (2005)
J. Biol. Chem. 280, 12271-12278
   Abstract »    Full Text »    PDF »
Fas-Mediated Apoptosis Is Dependent on Wild-Type p53 Status in Human Cancer Cells Expressing a Temperature-Sensitive p53 Mutant Alanine-143.
Y. Li, A. J. Raffo, L. Drew, Y. Mao, A. Tran, D. P. Petrylak, and R. L. Fine (2003)
Cancer Res. 63, 1527-1533
   Abstract »    Full Text »    PDF »
p53 Alterations Predict Tumor Response to Neoadjuvant Chemotherapy in Head and Neck Squamous Cell Carcinoma: A Prospective Series.
A. Cabelguenne, H. Blons, I. de Waziers, F. Carnot, A.-M. Houllier, T. Soussi, D. Brasnu, P. Beaune, O. Laccourreye, and P. Laurent-Puig (2000)
J. Clin. Oncol. 18, 1465-1473
   Abstract »    Full Text »    PDF »
Complete Sequencing of TP53 Predicts Poor Response to Systemic Therapy of Advanced Breast Cancer.
E. M. J. J. Berns, J. A. Foekens, R. Vossen, M. P. Look, P. Devilee, S. C. Henzen-Logmans, I. L. van Staveren, W. L. J. van Putten, M. Inganäs, M. E. M.-v. Gelder, et al. (2000)
Cancer Res. 60, 2155-2162
   Abstract »    Full Text »
Deletion of the COOH-Terminal Region of p73{{alpha}} Enhances Both Its Transactivation Function and DNA-binding Activity but Inhibits Induction of Apoptosis in Mammalian Cells.
T. Ozaki, M. Naka, N. Takada, M. Tada, S. Sakiyama, and A. Nakagawara (1999)
Cancer Res. 59, 5902-5907
   Abstract »    Full Text »    PDF »
Identification of a Transactivation Activity in the COOH-Terminal Region of p73 Which Is Impaired in the Naturally Occurring Mutants Found inHuman Neuroblastomas.
N. Takada, T. Ozaki, S. Ichimiya, S. Todo, and A. Nakagawara (1999)
Cancer Res. 59, 2810-2814
   Abstract »    Full Text »    PDF »
Inhibition of hTAFII32-binding Implicated in the Transcriptional Repression by Central Regions of Mutant p53 Proteins.
S.-F. Tung, J.-Y. Chuang, C.-T. Lin, M.-Y. Lai, C.-W. Wu, and Y.-S. Lin (1999)
J. Biol. Chem. 274, 7748-7755
   Abstract »    Full Text »    PDF »
Regulation of Mutant p53 Temperature-sensitive DNA Binding.
P. Friedlander, Y. Legros, T. Soussi, and C. Prives (1996)
J. Biol. Chem. 271, 25468-25478
   Abstract »    Full Text »    PDF »
p53 and Breast Cancer.
P. Robbins (1996)
International Journal of Surgical Pathology 4, 93-110
   Abstract »    PDF »
p53 Stimulates Promoter Activity of the sgk Serum/Glucocorticoid-inducible Serine/Threonine Protein Kinase Gene in Rodent Mammary Epithelial Cells.
A. C. Maiyar, A. J. Huang, P. T. Phu, H. H. Cha, and G. L. Firestone (1996)
J. Biol. Chem. 271, 12414-12422
   Abstract »    Full Text »    PDF »
Transcription-Factor Mutations and Disease.
D. S. Latchman (1996)
N. Engl. J. Med. 334, 28-33
   Full Text »    PDF »
Cytostatic gene therapy for vascular proliferative disorders with a constitutively active form of the retinoblastoma gene product.
M. Chang, E Barr, J Seltzer, Y. Jiang, G. Nabel, E. Nabel, M. Parmacek, and J. Leiden (1995)
Science 267, 518-522
   Abstract »    PDF »
CMV-p53 interaction may help explain clogged arteries.
J Marx (1994)
Science 265, 320
   PDF »


To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)